Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study - Takeaway - MDSpire

Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study

Share

  • 1

    Dysbiosis in chronic kidney disease (CKD) leads to an overgrowth of harmful bacteria and increased production of uraemic toxins.

  • 2

    Alterations in the gut microbiome of CKD patients are linked to the accumulation of uraemic toxins, which contribute to CKD progression.

  • 3

    Faecal microbiota transplantation in CKD mice showed increased serum uraemic toxins and slight kidney fibrosis, indicating microbiome's role in kidney damage.

  • 4

    Rapid kidney function decline in CKD is associated with gut microbiome-derived metabolites, independent of traditional risk factors.

  • 5

    Dietary interventions, like plant-based, low-protein diets, may mitigate the effects of dysbiosis and uraemic toxin accumulation in CKD.

Original Source(s)

Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study

  • by Cheuk Chun Szeto, Jack K C Ng

  • May 1, 2026

Related Content

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Is Long COVID Affecting the Heart?

Study points to increased cardiovascular events post-infection

  • April 17, 2026

  • 2 min
ApoB Goal Cost-Effective in Primary Prevention

Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals